[title missed]

Corresponding author: Shao Xiying, shaoxy@zjcc.org.cn

DOI: 10.12201/bmr.202504.00058

•  

  Abstract: [abstract missed]

  Key words: ; ; ; 

  Submit time: 18 April 2025

  Copyright: The copyright holder for this preprint is the author/funder, who has granted biomedRxiv a license to display the preprint in perpetuity.
• html

• 图表

• Yao Genwu, Wang Yanwei, Guo Jinyi, Li Lulu, Dang Wenbo, Song Ailin. Advances in single-cell sequencing in the breast cancer. 2024. doi: 10.12201/bmr.202407.00053

  Zhang zhenwen. Effects of SGLT2 inhibitors on the metabolic syndrome and its components. 2025. doi: 10.12201/bmr.202503.00002

  ZHAO Qing, JING Jiangxin. Advances in the application of ultrasound-based radiomics in predicting molecular typing of breast cancer. 2024. doi: 10.12201/bmr.202410.00040

  Wuhuan, Luoyushuang. Circulating Tumor Cell HER-2 Expression in the Targeted Therapy of Gastric Adenocarcinoma. 2024. doi: 10.12201/bmr.202408.00001

  李娜, Luo bingqing. Clinical observation of microwave ablation combined with chemotherapy and PD-1 inhibitor for non-small cell lung cancer.. 2025. doi: 10.12201/bmr.202504.00054

  Shirong Wang, Yalong Dang. The intraocular pressure lowering effects of ROCK inhibitor: the current concepts and perspectives. 2022. doi: 10.12201/bmr.202210.00014

  Shi Shenghong. . 2024. doi: 10.12201/bmr.202411.00062

  杨鹤, zhaoqing, zhaihong. . 2024. doi: 10.12201/bmr.202411.00032

  Zhaoqing, Jing Jiangxin. Progress and status of ultrasound imaging in breast cancer. 2024. doi: 10.12201/bmr.202412.00053

  ruanxuling, liuqi, guo zhiheng, yanjunfeng. Research on prediction model of breast cancer based on LDA and XGBoost algorithm. 2022. doi: 10.12201/bmr.202106.00007

• ID	Submit time	Number	Download
  1	2025-03-31	bmr.202504.00058V1	Download

• Public  Anonymous  To author only Submit Comments